Document 0299 DOCN M9460299 TI Intracellular analysis of in vitro modified HIV Tat protein. DT 9404 AU Koken SE; Greijer AE; Verhoef K; van Wamel J; Bukrinskaya AG; Berkhout B; Department of Virology, University of Amsterdam, The Netherlands. SO J Biol Chem. 1994 Mar 18;269(11):8366-75. Unique Identifier : AIDSLINE MED/94179219 AB Human immunodeficiency viruses HIV-1 and HIV-2 encode a Tat protein that specifically activates transcription from the viral long terminal repeat. To characterize the properties of the Tat proteins, we have expressed them in Escherichia coli. The purified Tat protein was biochemically analyzed and tested for activity upon electroporation into human cell lines. This protein electroporation was used for the intracellular analysis of in vitro modified Tat protein. Our results indicate that the transcriptionally active form of the Tat protein is a monomer. Furthermore, we found that Tat activity is dramatically inhibited by preincubation of the protein with strongly reducing agents. In contrast, no inhibitory effect was measured upon incubation with metal-chelating reagents. These results suggest that the cysteine residues of Tat are involved in the formation of intramolecular disulfide bonds. DE Base Sequence Cadmium/METABOLISM/PHARMACOLOGY Cell Line Chloramphenicol Acetyltransferase/METABOLISM Dithionitrobenzoic Acid Dithiothreitol/PHARMACOLOGY DNA Primers Electroporation Gene Products, tat/BIOSYNTHESIS/ISOLATION & PURIF/*METABOLISM Glutathione Transferases/BIOSYNTHESIS/ISOLATION & PURIF/ METABOLISM Human HIV-1/*METABOLISM HIV-2/*METABOLISM Kinetics Molecular Sequence Data Oxidation-Reduction Polymerase Chain Reaction Recombinant Fusion Proteins/BIOSYNTHESIS/ISOLATION & PURIF/ METABOLISM RNA-Binding Proteins/METABOLISM Sulfhydryl Compounds/PHARMACOLOGY Support, Non-U.S. Gov't T-Lymphocytes Transfection Zinc/METABOLISM/PHARMACOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).